Drug Database
PE

perimentase (BFM90 / BFM 90 / perimentase)

✓ Approved

Jiangsu Hengrui Pharmaceuticals · Small Molecule · Small Molecule

What is perimentase?

perimentase is a small molecule developed by Jiangsu Hengrui Pharmaceuticals. It is approved for therapeutic indications via unknown.

Drug Profile

Brand NamesBFM90, BFM 90, perimentase
CompanyJiangsu Hengrui Pharmaceuticals
Drug ClassSmall Molecule
RouteUnknown
StatusApproved
Sources: ClinicalTrials.gov, Jiangsu Hengrui Pharmaceuticals

Therapeutic Indications

perimentase is developed for 1 unique indication across 1 therapeutic area.

Therapeutic AreaConditionPhase
Neoplasms benign, malignant and unspecified (incl cysts and polyps)T-cell lymphoma✓ Approved

Ask about perimentase